FBTCX vs. BITO

In the year-to-date period, FBTCX achieves a -7.64% return, which is significantly lower than BITO's 9.30% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

FBTCX has a 1.75% expense ratio, which is higher than BITO's 0.95% expense ratio.

This table presents a comparison of risk-adjusted performance metrics for Fidelity Advisor Biotechnology Fund Class C (FBTCX) and ProShares Bitcoin Strategy ETF (BITO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current FBTCX Sharpe Ratio is -0.27, which is lower than the BITO Sharpe Ratio of 0.80. The chart below compares the historical Sharpe Ratios of FBTCX and BITO, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

FBTCX's dividend yield for the trailing twelve months is around 7.40%, less than BITO's 57.63% yield.

The maximum FBTCX drawdown since its inception was -61.27%, smaller than the maximum BITO drawdown of -77.86%. Use the drawdown chart below to compare losses from any high point for FBTCX and BITO.

Fidelity Advisor Biotechnology Fund Class C (FBTCX) and ProShares Bitcoin Strategy ETF (BITO) have volatilities of 9.98% and 9.55%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.